Request a document copy: Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study

all files (of this document) in restricted access
the file(s) you requested
Cancel